Ido joined Treato in April 2012, adding his diversified business and management track record to the leadership team. Prior to Treato, Ido led Commtouch Software (Nasdaq: CTCH), a cloud-based Internet Security solution provider, where as CEO he successfully refocused the company's strategy and accelerated its growth. Prior to Commtouch, Ido spent 8 years at Interwise, an enterprise conferencing provider acquired by AT&T, holding an array of business leadership roles across international markets. Ido holds a BA magna cum laude in Business Administration and Economics from Hebrew University, Jerusalem.

Roee was Treato's first employee, forging all the technological teams in the company's first stages and becoming the leadership glue connecting them. Prior to Treato, Roee worked in the lab of Prof. Yuval Shahar, head of the Medical Informatics Research Center at Ben Gurion University, on a concept based search engine while writing his thesis: "Mining Meaningful Clinical Association Rules from Patient Reports." Roee received his B.Sc and M.Sc in Information Systems Engineering from Ben Gurion University.

Assaf was hired to scale Treato's technology, and initiated a complete redesign of the infrastructure to the Hadoop platform, allowing Treato to download and parse 100 million posts a day. As VP R&D, Assaf drives innovation and execution on a daily basis. Prior to Treato, Assaf worked as a developer for Mainsoft which creates cross platform development tools, and assisted the company in bridging the gap between Microsoft and Java technologies. Before Mainsoft, Assaf was a programmer at Mediamind. Assaf received his B.Sc in Information Systems Engineering from Ben Gurion University.

Gil is the creative engine propelling Treato. Leading the development and design of the company's products, Gil tackles the challenge of getting into users' minds and meeting their wants and needs with an efficiently designed interface. Prior to joining Treato, Gil was senior Product Manager at Wix, a start-up that revolutionized the world of retail web design with a platform to create free Flash websites. Before Wix, Gil was Head of Product at Quicksee, an online virtual tour site later acquired by Google. Gil received his BA from Mercy College, and a diploma from the Israeli Academy of Commercial Communications.

Yaron has over a decade of healthcare ad agency experience in which he established and broadened the reach of leading pharmaceutical brands, and achieved several industry awards for his work. He held a series of leadership roles in Omnicom and Publicis agencies, two of the largest healthcare communication, advertising and marketing groups. Prior to joining Treato, in his most recent role at Flashpoint Medica (part of the Omnicom network), he led the agency's strategic services and business development departments; overseeing notable new business wins and key account growth. Yaron holds a Bachelors of Business in Marketing from Hofstra University.

With two decades of experience in an industry built on large scale data, Gideon envisioned how big data technology could impact the healthcare domain, the last Internet frontier. His track record as an entrepreneur enabled him to turn this abstract concept into a reality. Prior to Treato, Gideon co-founded Commtouch Ltd. and was on the executive team for 20 years. As chairman and CEO, Gideon successfully led Commtouch to the leadership position in the outsourced global email and messaging services industry. Before Commtouch, Gideon was co-founder and CEO of Financial Leverages Ltd. and also served as the CFO of the Gali Group, one of Israel's largest consumer product companies. Gideon received a BA in Political Science and an MBA in Finance from Tel Aviv University.

One of the founding partners of Reed Elsevier Ventures and serves as its Managing Director, Mr. Askew joined Reed Elsevier Ventures in 2000 from the SOFTBANK/ News Corporation European joint venture fund, eVentures. Prior to that, he led Arthur Andersen's eBusiness service line in Europe. Mr. Askew also held an executive position at BT Cellnet (now O2) where he launched the world's first wireless internet service provider, Genie. In addition to Treato, he currently serves on the boards of Babylon, Partminer and Spacecurve. Mr. Askew received his B.Sc. in Physics from the University of London.

Anat Naschitz, Managing Director at OrbiMed, has over 18 years of international healthcare operational and investment experience. OrbiMed Advisors LLC is a leading healthcare investment firm, with approximately $7 billion in assets under management. OrbiMed invests globally out of five offices – New York, Tel Aviv, San Francisco, Shanghai and Mumbai – in private and public companies across stages, through a series of funds. OrbiMed Israel has $222 million in committed capital.
Prior to OrbiMed, Anat spent seven years with McKinsey & Company in London, where she was an Associate Partner, managing strategy, M&A and marketing projects for senior leadership of the world’s preeminent pharmaceutical and biotechnology companies. Anat led the work which catalyzed pharmaceutical spinouts, resulting in the creation of two European biotech companies, which subsequently had IPOs for over $1 billion. Anat then joined Apax Partners, where she focused on life sciences investments. Subsequently, Anat worked with investors and companies on transactions and corporate strategy and served as a director/advisor to the boards of multiple medical device, biopharmaceutical and health IT companies. She earned her MBA at INSEAD and her LLB at Tel Aviv University.

Philippe Chambon is a Managing Director and founder of New Leaf Venture Partners, a spin-off from The Sprout Group. He joined Sprout in May 1995 and became a General Partner in January 1997. He invests broadly in healthcare technology companies. He currently sits on the boards of NxStage Medical (NXTM), Karos Pharmaceuticals, VaxInnate Corporation, Truveris, Inc. and Principia Biopharma. Past representative investments include Auxilium Pharmaceuticals (AUXL), Cephalon, ePocrates (EPOC, acquired by athenahealth), Phase Forward (PFWD, acquired by Oracle) and Spotfire (acquired by Tibco).
Previously, Philippe served as Manager in the Healthcare Practice of The Boston Consulting Group from May 1993 to April 1995. From September 1987 to April 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a MD, Ph.D. from the University of Paris. Philippe also has an MBA from Columbia University in New York.